NCT05284721 Family Peer Navigator for Early Psychosis for Black Families
| NCT ID | NCT05284721 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington State University |
| Condition | Family Members |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-01-01 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Building upon formative research, this mixed methods study will be conducted in three phases to develop, refine, and pilot-test a multi-component Family Peer Navigator model designed to increase access to and initial engagement in coordinated specialty care for early psychosis among Black/African American families.
Eligibility Criteria
Inclusion Criteria: 1. ≥ 18 years of age 2. Identifies as Black/African American 3. Loved one who meets criteria for risk of psychosis with a total score of ≥ 3 on the Prodromal Questionnaire- Brief Version Exclusion Criteria: 1. Family members who cannot understand the consent process 2. Non-English speaking adults 3. Black/African American families referred to coordinated specialty care and who have already been determined eligible for services by providers.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05284721 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Family Members. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05284721 currently recruiting?
Yes, NCT05284721 is actively recruiting participants. Contact the research team at oladunni.oluwoye@wsu.edu for enrollment information.
Where is the NCT05284721 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT05284721 clinical trial?
NCT05284721 is sponsored by Washington State University. The trial plans to enroll 50 participants.